Promoter-proximal pausing of RNA polymerase II defines a general rate-limiting step after transcription initiation.

We have shown previously that the majority of RNA polymerase II complexes initiated at the c-myc gene are paused in the promoter-proximal region, similar to observations in the Drosophila hsp70 gene. Our analyses define the TATA box or initiator sequences in the c-myc gene as necessary components for the establishment of paused RNA polymerase II. Deletion of upstream sequences or even the TATA box does not influence significantly the degree of transcriptional initiation or pausing. Deletion of both the TATA box and sequences at the transcription initiation site, however, abolishes transcriptional pausing of transcription complexes but still allows synthesis of full-length RNA. Further analyses with synthetic promoter constructs reveal that the simple combination of upstream activator with TATA consensus sequences or initiator sequences act synergistically to recruit high levels of RNA polymerase II complexes. Only a minor fraction of these complexes escapes into regions further downstream. Several different trans-activation domains fused to GAL4-DNA-binding domains, including strong activators such as VP16, do not eliminate promoter-proximal pausing of RNA polymerase. Thus, we conclude that pausing of RNA polymerase II is a common phenomenon in eukaryotic transcription and does not require complex promoter structures. Further analyses reveal that enhancers have a modest influence on transcription initiation and on release of transcription complexes out of the pause site but may function primarily to increase the elongation competence of transcription complexes.

[1]  D. Reinberg,et al.  Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53 , 1994, Molecular and cellular biology.

[2]  L. Madisen,et al.  Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells. , 1994, Genes & development.

[3]  H. Ding,et al.  Stimulation of RNA polymerase II elongation by chromosomal protein HMG-14. , 1994, Science.

[4]  J. Gralla,et al.  A critical role for chromatin in mounting a synergistic transcriptional response to GAL4-VP16 , 1994, Molecular and cellular biology.

[5]  J. Lis,et al.  Phosphorylation of RNA polymerase II C-terminal domain and transcriptional elongation , 1994, Nature.

[6]  D. Bentley,et al.  Transcriptional elongation by RNA polymerase II is stimulated by transactivators , 1994, Cell.

[7]  R. Tjian,et al.  Transcription factors IIE and IIH and ATP hydrolysis direct promoter clearance by RNA polymerase II , 1994, Cell.

[8]  R. Tjian,et al.  Transcription factor IIE binds preferentially to RNA polymerase IIa and recruits TFIIH: a model for promoter clearance. , 1994, Genes & development.

[9]  D. Luse,et al.  RNA polymerase II promoter strength in vitro may be reduced by defects at initiation or promoter clearance. , 1994, The Journal of biological chemistry.

[10]  Michael R. Green,et al.  Eukaryotic activators function during multiple steps of preinitiation complex assembly , 1993, Nature.

[11]  J. M. Lee,et al.  Locus-specific variation in phosphorylation state of RNA polymerase II in vivo: correlations with gene activity and transcript processing. , 1993, Genes & development.

[12]  M. Groudine,et al.  Common mechanisms for the control of eukaryotic transcriptional elongation , 1993, BioEssays : news and reviews in molecular, cellular and developmental biology.

[13]  M. Groudine,et al.  Distinct properties of c-myc transcriptional elongation are revealed in Xenopus oocytes and mammalian cells and by template titration, 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB), and promoter mutagenesis , 1993, Molecular and cellular biology.

[14]  J. Lis,et al.  In vivo transcriptional pausing and cap formation on three Drosophila heat shock genes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[15]  L. Johnson,et al.  Lack of an initiator element is responsible for multiple transcriptional initiation sites of the TATA-less mouse thymidylate synthase promoter , 1993, Molecular and cellular biology.

[16]  J. Lis,et al.  Protein traffic on the heat shock promoter: Parking, stalling, and trucking along , 1993, Cell.

[17]  B. Cullen Does HIV-1 Tat induce a change in viral initiation rights? , 1993, Cell.

[18]  B. Peterlin,et al.  The human immunodeficiency virus type 1 long terminal repeat specifies two different transcription complexes, only one of which is regulated by Tat , 1993, Journal of virology.

[19]  Jeffrey W. Roberts RNA and protein elements of E. coli and λ transcription antitermination complexes , 1993, Cell.

[20]  N. Hernandez,et al.  Characterization of the inducer of short transcripts, a human immunodeficiency virus type 1 transcriptional element that activates the synthesis of short RNAs , 1993, Molecular and cellular biology.

[21]  R. Roeder,et al.  Human transcription factor USF stimulates transcription through the initiator elements of the HIV‐1 and the Ad‐ML promoters. , 1993, The EMBO journal.

[22]  D. Herschlag,et al.  Synergism in transcriptional activation: a kinetic view. , 1993, Genes & development.

[23]  J. Roberts RNA and protein elements of E. coli and lambda transcription antitermination complexes. , 1993, Cell.

[24]  J. Greenblatt,et al.  Transcriptional antitermination , 1993, Nature.

[25]  J. T. Kadonaga,et al.  Mechanism of transcriptional antirepression by GAL4-VP16. , 1992, Genes & development.

[26]  M. Groudine,et al.  The block to transcriptional elongation within the human c-myc gene is determined in the promoter-proximal region. , 1992, Genes & development.

[27]  J. Lis,et al.  Promoter melting and TFIID complexes on Drosophila genes in vivo. , 1992, Genes & development.

[28]  M. Groudine,et al.  Sequences in the human c-myc P2 promoter affect the elongation and premature termination of transcripts initiated from the upstream P1 promoter , 1992, Molecular and cellular biology.

[29]  J. Greenblatt,et al.  Host factor requirements for processive antitermination of transcription and suppression of pausing by the N protein of bacteriophage lambda. , 1992, The Journal of biological chemistry.

[30]  H. Olsen,et al.  Contribution of the TATA motif to Tat-mediated transcriptional activation of human immunodeficiency virus gene expression , 1992, Journal of virology.

[31]  J. Gralla,et al.  The acidic activator GAL4-AH can stimulate polymerase II transcription by promoting assembly of a closed complex requiring TFIID and TFIIA. , 1992, Genes & development.

[32]  D. Eick,et al.  Hold back of RNA polymerase II at the transcription start site mediates down‐regulation of c‐myc in vivo. , 1992, The EMBO journal.

[33]  P. Chambon,et al.  The acidic transcriptional activator GAL‐VP16 acts on preformed template‐committed complexes. , 1992, The EMBO journal.

[34]  G. Chinnadurai,et al.  Synergistic activation of the human immunodeficiency virus type 1 promoter by the viral Tat protein and cellular transcription factor Sp1 , 1992, Journal of virology.

[35]  D. Price,et al.  Stability of Drosophila RNA polymerase II elongation complexes in vitro , 1992, Molecular and cellular biology.

[36]  D. Price,et al.  Control of formation of two distinct classes of RNA polymerase II elongation complexes , 1992, Molecular and cellular biology.

[37]  P. Bernstein,et al.  Control of c-myc mRNA half-life in vitro by a protein capable of binding to a coding region stability determinant. , 1992, Genes & Development.

[38]  R. Roeder,et al.  HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. , 1992, Genes & development.

[39]  J. Lis,et al.  DNA sequence requirements for generating paused polymerase at the start of hsp70. , 1992, Genes & development.

[40]  B. Berkhout,et al.  Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat , 1992, Journal of virology.

[41]  M. Green,et al.  The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: implications for Tat function. , 1991, Genes & development.

[42]  J. Lis,et al.  RNA polymerase II pauses at the 5' end of the transcriptionally induced Drosophila hsp70 gene , 1991, Molecular and cellular biology.

[43]  G. Chinnadurai,et al.  Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Gralla,et al.  Differential ability of proximal and remote element pairs to cooperate in activating RNA polymerase II transcription , 1991, Molecular and cellular biology.

[45]  D. Luse,et al.  Transcription on nucleosomal templates by RNA polymerase II in vitro: inhibition of elongation with enhancement of sequence-specific pausing. , 1991, Genes & development.

[46]  D. Reinberg,et al.  Role of the mammalian transcription factors IIF, IIS, and IIX during elongation by RNA polymerase II , 1991, Molecular and cellular biology.

[47]  J. Workman,et al.  Activation domains of stably bound GAL4 derivatives alleviate repression of promoters by nucleosomes , 1991, Cell.

[48]  N. Hernandez,et al.  The HIV-1 long terminal repeat contains an unusual element that induces the synthesis of short RNAs from various mRNA and snRNA promoters. , 1990, Genes & development.

[49]  D. Baltimore,et al.  Transcriptional activation by Sp1 as directed through TATA or initiator: specific requirement for mammalian transcription factor IID. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[50]  M. Groudine,et al.  Transcription elongation and eukaryotic gene regulation. , 1990, Oncogene.

[51]  Michael Carey,et al.  A mechanism for synergistic activation of a mammalian gene by GAL4 derivatives , 1990, Nature.

[52]  Michael Carey,et al.  How different eukaryotic transcriptional activators can cooperate promiscuously , 1990, Nature.

[53]  W. S. Hayward,et al.  The block to transcription elongation is promoter dependent in normal and Burkitt's lymphoma c-myc alleles. , 1990, Genes & development.

[54]  M. Mathews,et al.  HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation , 1989, Cell.

[55]  M Lipp,et al.  Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter. , 1989, Genes & development.

[56]  R. Gaynor,et al.  Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation. , 1989, The EMBO journal.

[57]  Jun Ma,et al.  GAL4-VP16 is an unusually potent transcriptional activator , 1988, Nature.

[58]  A. Rougvie,et al.  The RNA polymerase II molecule at the 5′ end of the uninduced hsp70 gene of D. melanogaster is transcriptionally engaged , 1988, Cell.

[59]  Mark Ptashne,et al.  Negative effect of the transcriptional activator GAL4 , 1988, Nature.

[60]  P. Luciw,et al.  Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product , 1987, Nature.

[61]  D. Eick,et al.  Transcriptional arrest within the first exon is a fast control mechanism in c-myc gene expression. , 1986, Nucleic acids research.

[62]  K. Marcu,et al.  Intragenic pausing and anti‐sense transcription within the murine c‐myc locus. , 1986, The EMBO journal.

[63]  Mark Groudine,et al.  A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells , 1986, Nature.

[64]  M. Ptashne,et al.  Separation of DNA binding from the transcription-activating function of a eukaryotic regulatory protein. , 1986, Science.

[65]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[66]  M. Groudine,et al.  Interaction of HMG 14 and 17 with actively transcribed genes , 1980, Cell.